Induced drug resistance inhibits selection of initiated cells and cancer development

Carcinogenesis

Volumn 18, Issue 4, 1997, Pages 649-655

  Rissler, P ^a   Torndal, U B ^a   Eriksson, L C ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; N (2 FLUORENYL)ACETAMIDE; PHENOBARBITAL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; DRUG RESISTANCE; LABELING INDEX; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER WEIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR PROMOTION;

2-ACETYLAMINOFLUORENE; ANIMALS; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; DRUG RESISTANCE, NEOPLASM; LIVER; LIVER REGENERATION; MALE; METHYLCHOLANTHRENE; ORGAN SIZE; PHENOBARBITAL; RATS; RATS, WISTAR;

EID: 0031408651     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.4.649     Document Type: Article

References (49)

1. Farber, E. (1990) Clonal adaptation during carcinogenesis. Biochem. Pharmacol., 39, 1837-1846.
2. Farber, E. and Sarma, D.S.R. (1987) Hepatocarcinogenesis: A dynamic cellular perspective. Lab. Invest., 56, 4-21.
3. Solt, D.B. and Farber, E. (1976) New principle for the analyses of chemical carcinogenesis. Nature, 263, 702-703.
4. Tatematsu, M., Aoki, T., Kagawa, M., Mera, Y. and Ito, N. (1988) Reciprocal relationship between development of glutathione S-transferase positive liver foci and proliferation of surrounding hepatocytes in rat. Carcinogenesis, 9, 221-225.
5. Farber, E. (1982) Sequential events in chemical carcinogenesis. In Becker, F.F. (ed.) Cancer: A Comprehensive Treatise, Plenum Publishing Corporation, New York, p. 485.
6. Ito, N., Tsuda, H., Tatematsu, M., Inoue, T., Tagawa, Y., Aoki, T., Uwagawa, S., Kagawa, M., Ogiso, T., Masui, T., Imaida, K., Fukushima, S. and Asamoto, M. (1988) Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats - an approach for a new medium-term bioassay system. Carcinogenesis, 9, 387-389.
7. Eckl, P.M., Meyer, S.A., Whitcomb, W.R. and Jirtle, R.L. (1983) Phenobarbital reduces EGF receptors and the ability of physiological concentrations of calcium to suppress hepatocyte proliferation. Carcinogenesis, 9, 479-483.
8. Laconi, E., Li, F., Semple, E., Rao, P.M., Rajalakshmi, S. and Sarma, D.S.R. (1988) Inhibition of DNA synthesis in primary cultures of hepatocytes by orotic acid. Carcinogenesis, 9, 675-677.
9. Pichiri-Coni, G., Coni, P. Laconi, E., Schwarze, P.E., Seglen, P.O., Rao, P.M., Rajalakshmi, S. and Sarma, D.S.R. (1990) Studies on the mitoinhibitory effect of orotic acid on hepatocytes in primary culture. Carcinogenesis, 11, 981-984.
10. Schulte-Hermann, R., Ohde, G., Schuppler, J. and Timmerman-Trosiener, I. (1981) Enhanced proliferation of putative preneoplastic cells in rat liver following treatment with the tumor promoters, phenobarbital, hexachlorocyclohexane, steroid compounds, and nafenopin. Cancer Res., 41, 2556-2562.
11. Bursch, W., Lauer, B., Timmerman-Trosiener, I., Barthel, G., Schupper, J. and Schulte-Hermann, R. (1984) Controlled cell death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis, 5, 453-458.
12. Saeter, G., Schwarze, P.E., Nesland, J.M. and Seglen, P.O. (1988) 2-Acetylaminofluorene promotion of liver carcinogenesis by a non-cytotoxic mechanism. Carcinogenesis, 9, 581-587.
13. Eriksson, L.C., Torndal, U.-B. and Andersson, G.N. (1983) Isolation and charcterization of endoplasmic reticulum and Golgi apparatus from hepatocyte nodules in male Wistar rats. Cancer Res., 43, 3335-3347.
14. Roomi, M.W., Ho, R.K., Sarma, D.S.R. and Farber, E. (1985) A common biochemical pattern in preneoplastic hepalocyte nodules generated in four different models in the rat. Cancer Res., 45, 564-571.
15. Farber, E., Chen, Z.-Y. Harris, L., Lee, G., Rinaudo, J.S., Roomi, W.M., Rotstein, J. and Semple, E. (1989) The biochemical-molecular pathology of the stepwise development of liver cancer: new insights and problems. In Bannasch, P., Keppler, D. and Weber, G., (Eds.) Liver Cell Carcinoma, Kluwer Academic Publishers, pp. 273-291.
16. Erikssori, L.C., Blanck, A., Bock, K.W. and Mannervik, B. (1987) Metabolism of xenobiotics in hepatocyte nodules. Toxicol. Pathol., 15, 27-41.
17. Huitfeldt, H.S., Brandtzaeg, P. and Poirier, M.C. (1990) Reduced DNA adduct formation in replicating liver cells during continuous feeding of a chemical carcinogen. Proc. Natl Acad. Sci. USA, 87, 5955-5958.
18. Roomi, M.W., Ho, R.K., Sarma, D.S.R. and Farber, E. (1985) A common biochemical pattern in preneoplastic hepatocyte nodules generated in four different models in the rat. Cancer Res., 45, 564-571.
19. Eriksson, L.C. (1985) Aspects of drug metabolism in hepatocyte nodules in rats. In Matern, S., Bock, K.W. and Gerok, W. (eds.) Advances in Glucoronide Conjugation. Limited Falcon House, Lancaster, pp. 295-308.
20. Buchmann, A., Kuhlmann, W., Schwarz, M., Kunz, W., Wolf, C.R., Moll, E., Friedberg, T. and Oesch, F. (1985) Regulation and expression of four cytochrome P-450 isoenzymes, NADPH-cytochrome P-450 reductase, the glutathione transferases B and C and microsomal epoxide hydrolase in preneoplastic and neoplastic lesions in rat liver. Carcinogenesis, 6, 513-521.
21. Astrom, A., DePierre, J.W. and Eriksson, L. (1983) Characterization of drug-metabolizing systems in hyperplastic nodules from the livers of rats receiving 2-Acetylaminofluorene in their diet. Carcinogenesis, 4, 577-581.
22. Eriksson, L.C. and Andersson, G.N. (1992) Membrane biochemistry and chemical hepatocarcinogenesis. Crit. Rev. Biochem. Mol., 27, 1-55.
23. Blanck, A., Wiksell, L. and Eriksson, L.C. (1987) Sulfation of N-hydroxy-2-Acetylaminofluorene in normal and nodular liver from male Wistar rats. Toxicol. Pathol., 15, 103-105.
24. Shirai, T.K., King, C.M. (1982) Sulfotransferase and deacetylase in normal and tumor-bearing liver of CD-rats: Autoradiographical studies with N-hydroxy-2-acetylaminohiphenyl in vitro and in vivo. Carcinogenesis, 3, 1385-1391.
25. Ahluwahlia, M.B. (1984) Glutathione metabolism in early hepatocyte nodules during liver Carcinogenesis, University of Toronto, M. Sc. Thesis.
26. Olsson, J.M., Eriksson, L.C. and Dallner, G. (1991) Lipid compositions of intracellular membranes isolated from rat liver nodules in Wistar rats. Cancer Res., 51, 3774-3780.
27. Eriksson, L.C. (1973) Studies on the biogenesis of endoplasmic reticulum in the liver cell. Acta Pathol. Microbiol. Scand., sect. A, Suppl. No. 239, 1-72.
28. Cramer, J.W. Miller, J.A. and Miller, E.C. (1960) N-Hydroxylation: A new metabolic reaction observed in the rat with the carcinogen 2-acetylaminofluorene. J. Biol. Chem., 235, 885-888.
29. DeBaun, J.R., Miller, E.C. and Miller, J.A. (1970) N-Hydroxy-2-Acetylaminofluorene sulfotransferase: its probable role in carcinogenesis and in protein-(methion-S-yl) binding in rat liver. Cancer Res., 30, 577-595.
30. Tiwawech, D., Hasegawa, R., Kurata, Y., Tatematsu, M., Shibata, M-A., Thamavit, W. and Ito, N. (1991) Dose-dependent effects of 2-Acetylaminofluorene on hepatic foci development and cell proliferation in rats. Carcinogenesis, 12, 985-990.
31. Yager, J.D., Zurlo, J., Sewall, C.H., Lucier, G.W. and He, H. (1994) Growth stimulation followed by growth inhibition in livers of female rats treated with ethinyl estradiol. Carcinogenesis, 15, 2117-2123.
32. Eriksson, L.C., Torndal, U-B. and Andersson, G.N. (1983) Isolation and characterization of endoplasmic reticulum and golgi apparatus from hepatocyte nodules in male Wistar rats. Cancer Res., 43, 3335-3347.
33. Spiewak Rinaudo, J.A. and Farber, E. (1986) The pattern of metabolism of 2-Acetylaminofluorene in carcinogen induced hepatocyte nodules in comparison to normal liver. Carcinogenesis, 7, 523-528.
34. Kroese, D.E., Tijdens, B., Mulder, G.J. and Meerman, J.H.N. (1987) Autoradiographic studies on in vivo covalent binding of N-hydroxy-2-Acetylaminofluorene in rat liver containing gamma-glutamyltranspeptidase-positive foci. The effect of the sulfation-inhibitor pentachlorophenol. Carcinogenesis, 8, 571-575.
35. Kroese, D.E., van de Poll, M.L.M., Mulder, G.J. and Meerman, J.H.N. (1988) The role of N-sulfation in the N-hydroxy-2-acetylaminofluorene-mediated outgrowth of diethylnitrosamine-initiated hepatocytes to gamma-glutamyltranspeptidase-positive foci in rat liver. Carcinogenesis, 9, 1953-1958.
36. Meerman, J.H.N. (1985) The initiation of gamma-glutamyltranspeptidase positive foci in the rat liver by N-hydroxy-2-acetylaminofluorene. The effect of the sulfation inhibitor pentachlorophenol. Carcinogenesis, 6, 893-897.
37. Astrom, A., Meijer, J. and DePierre, J.W. (1983) Characterization of the microsomal cytochrome P-450 species induced in rat liver by 2-acetylaminofluorene. Cancer Res., 43, 342-348.
38. Spiewak Rinaudo, J.N., ErikssonL, C., Roomi, M.W. and Farber, E. (1989) Kinetics of excretion of 2-Acetylaminofluorene in normal and xenobiotic treated rats and in rats with hepatocyte nodules. Lab. Invest., 60, 399-408.
39. Bock, K.W., Lilienblum, W., Pfeil, H. and Eriksson, L.C. (1982) Increased uridine diphosphate-glucuronyltransferase activity in preneoplastic liver nodules and Morris hepatomas. Cancer Res., 42, 3747-3752.
40. Bock, K.W., Schirmer, G., Green, M.D. and Tephly, T.R. (1988) Properties of a 3-methylcholanthrene-inducible phenol UDP-glucuronosyltransferase from rat liver. Biochem. Pharmacol., 37, 1439-1443.
41. Bock, K.W., Münzel, P.A., Röhrdanz, E., Schrenk, D. and Eriksson, L.C. (1990) Persistently increased expression of a 3-methylcholanthrene-inducible phenol uridine diphosphate-glucuronosyltransferase in rat hepatocyte nodules and hepatocellular carcinomas. Cancer Res., 50, 3569-3573.
42. Johansson-Stromblad, S., Eriksson, L.C. and Andersson, G. (1994) Increased expression of and sensitivity to transforming growth factor-α suggest a promotive role during rat liver carcinogenesis. Mol. Carcinog., 10, 97-104.
43. Norstedt, G., Levinovitz, A., Moller, C., Eriksson, L.C. and Andersson, G. (1988) Expression of insulin-like growth factor I (IGF I) and IGF II during hepatic development, proliferation and carcinogenesis in the rat. Carcinogenesis, 9, 209-213.
44. Nilsson, H. and Eriksson, L.C. (1994) Growth factor induced mitogenic effects and inositol phosphate responses in primary hepatocyte cultures from normal rat liver and rat liver nodules. Carcinogenesis, 15, 1821-1826.
45. Schulte-Hermann, R., Grasl-Kraupp, B. and Bursch, W. (1994) Tumor development and apoptosis. Int. Arch. Allergy Immunol., 105, 363-367.
46. Schulte-Hermann, R., Bursch, W., Kraupp-Grasl, B., Oberhammer, F., Wagner, A and Jirtle, R. (1993) Cell proliferation and apoptosis in normal liver and preneoplastic foci. Environ. Health Perspect., 101, Suppl 5, 87-90.
47. Flaks, A. and Flaks, B. (1982) 3-Methylcholantrene-inhibition of hepatocarcinogenesis in the rat due to 3′-methyl-4-dimethylamino-azobenzene or 2-acetylaminofluorene: a comparative study. Carcinogenesis, 3, 981-991.
48. Periano, C., Fry, R.J.M. and Staffeldt, E. (1971) Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2-acetylaminofluorene. Cancer res., 31, 1506-1512.
49. Hayes, M.A., Roberts, E., Safe, S.H., Farber, E. and Cameron, R.G. (1986) Influences of different polychlorinated biphenyls on cytocidal, mitoinhibitory, and nodule-selecting activities of N-2-fluorenylacetamid in rat liver. J. Natl Cancer I, 4, 686-691.